Global Cloud-Based Drug Discovery Platforms Market Research Report 2023

Publication ID:

PB504231097

Publication Date:

April 12, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Among the various end users of cloud-based drug discovery platforms, pharmaceutical vendors are likely to be major stakeholders holding a high value share of the global cloud-based drug discovery platform market. An opportunity analysis of the global market reveals that leading software vendors have already adopted cloud-based drug discovery platforms to facilitate seamless research and development processes. As there is less adoption of these cloud-based platforms in several countries of the MEA, public and private ventures are taking initiatives to invest in the R&D process in this region. Moreover, the MEA cloud-based drug discovery platform revolution will witness significant growth in the coming years, thereby creating better opportunities for software vendors for growth and expansion.
Highlights
The global Cloud-Based Drug Discovery Platforms market was valued at US$ 1075.1 million in 2022 and is anticipated to reach US$ 1668.4 million by 2029, witnessing a CAGR of 7.6% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Keeping the needs of consumers in mind, key players in the cloud-based drug discovery platform are offering flexible, cost-effective, and highly secure cloud-based storage options to consumers. Cloud-based drug discover platform runs at zero lag time, saving time and giving real-time access to users. This is another reason for the growing adoption of cloud-based drug discovery platform globally.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cloud-Based Drug Discovery Platforms, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cloud-Based Drug Discovery Platforms.
The Cloud-Based Drug Discovery Platforms market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cloud-Based Drug Discovery Platforms market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cloud-Based Drug Discovery Platforms companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
IBM
Accenture
Tata Consultancy Services
SAS Institute
BioXcel
Cloud Pharmaceuticals
WuXi AppTec
Dassault System
Acelot
Segment by Type
IaaS
PaaS
SaaS
Segment by Application
Hospitals
Pharmaceutical Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cloud-Based Drug Discovery Platforms companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cloud-Based Drug Discovery Platforms Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 IaaS
1.2.3 PaaS
1.2.4 SaaS
1.3 Market by Application
1.3.1 Global Cloud-Based Drug Discovery Platforms Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cloud-Based Drug Discovery Platforms Market Perspective (2018-2029)
2.2 Cloud-Based Drug Discovery Platforms Growth Trends by Region
2.2.1 Global Cloud-Based Drug Discovery Platforms Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cloud-Based Drug Discovery Platforms Historic Market Size by Region (2018-2023)
2.2.3 Cloud-Based Drug Discovery Platforms Forecasted Market Size by Region (2024-2029)
2.3 Cloud-Based Drug Discovery Platforms Market Dynamics
2.3.1 Cloud-Based Drug Discovery Platforms Industry Trends
2.3.2 Cloud-Based Drug Discovery Platforms Market Drivers
2.3.3 Cloud-Based Drug Discovery Platforms Market Challenges
2.3.4 Cloud-Based Drug Discovery Platforms Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cloud-Based Drug Discovery Platforms Players by Revenue
3.1.1 Global Top Cloud-Based Drug Discovery Platforms Players by Revenue (2018-2023)
3.1.2 Global Cloud-Based Drug Discovery Platforms Revenue Market Share by Players (2018-2023)
3.2 Global Cloud-Based Drug Discovery Platforms Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cloud-Based Drug Discovery Platforms Revenue
3.4 Global Cloud-Based Drug Discovery Platforms Market Concentration Ratio
3.4.1 Global Cloud-Based Drug Discovery Platforms Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cloud-Based Drug Discovery Platforms Revenue in 2022
3.5 Cloud-Based Drug Discovery Platforms Key Players Head office and Area Served
3.6 Key Players Cloud-Based Drug Discovery Platforms Product Solution and Service
3.7 Date of Enter into Cloud-Based Drug Discovery Platforms Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cloud-Based Drug Discovery Platforms Breakdown Data by Type
4.1 Global Cloud-Based Drug Discovery Platforms Historic Market Size by Type (2018-2023)
4.2 Global Cloud-Based Drug Discovery Platforms Forecasted Market Size by Type (2024-2029)
5 Cloud-Based Drug Discovery Platforms Breakdown Data by Application
5.1 Global Cloud-Based Drug Discovery Platforms Historic Market Size by Application (2018-2023)
5.2 Global Cloud-Based Drug Discovery Platforms Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cloud-Based Drug Discovery Platforms Market Size (2018-2029)
6.2 North America Cloud-Based Drug Discovery Platforms Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cloud-Based Drug Discovery Platforms Market Size by Country (2018-2023)
6.4 North America Cloud-Based Drug Discovery Platforms Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cloud-Based Drug Discovery Platforms Market Size (2018-2029)
7.2 Europe Cloud-Based Drug Discovery Platforms Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cloud-Based Drug Discovery Platforms Market Size by Country (2018-2023)
7.4 Europe Cloud-Based Drug Discovery Platforms Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cloud-Based Drug Discovery Platforms Market Size (2018-2029)
8.2 Asia-Pacific Cloud-Based Drug Discovery Platforms Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cloud-Based Drug Discovery Platforms Market Size by Region (2018-2023)
8.4 Asia-Pacific Cloud-Based Drug Discovery Platforms Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cloud-Based Drug Discovery Platforms Market Size (2018-2029)
9.2 Latin America Cloud-Based Drug Discovery Platforms Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cloud-Based Drug Discovery Platforms Market Size by Country (2018-2023)
9.4 Latin America Cloud-Based Drug Discovery Platforms Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cloud-Based Drug Discovery Platforms Market Size (2018-2029)
10.2 Middle East & Africa Cloud-Based Drug Discovery Platforms Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cloud-Based Drug Discovery Platforms Market Size by Country (2018-2023)
10.4 Middle East & Africa Cloud-Based Drug Discovery Platforms Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Cloud-Based Drug Discovery Platforms Introduction
11.1.4 IBM Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.1.5 IBM Recent Development
11.2 Accenture
11.2.1 Accenture Company Detail
11.2.2 Accenture Business Overview
11.2.3 Accenture Cloud-Based Drug Discovery Platforms Introduction
11.2.4 Accenture Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.2.5 Accenture Recent Development
11.3 Tata Consultancy Services
11.3.1 Tata Consultancy Services Company Detail
11.3.2 Tata Consultancy Services Business Overview
11.3.3 Tata Consultancy Services Cloud-Based Drug Discovery Platforms Introduction
11.3.4 Tata Consultancy Services Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.3.5 Tata Consultancy Services Recent Development
11.4 SAS Institute
11.4.1 SAS Institute Company Detail
11.4.2 SAS Institute Business Overview
11.4.3 SAS Institute Cloud-Based Drug Discovery Platforms Introduction
11.4.4 SAS Institute Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.4.5 SAS Institute Recent Development
11.5 BioXcel
11.5.1 BioXcel Company Detail
11.5.2 BioXcel Business Overview
11.5.3 BioXcel Cloud-Based Drug Discovery Platforms Introduction
11.5.4 BioXcel Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.5.5 BioXcel Recent Development
11.6 Cloud Pharmaceuticals
11.6.1 Cloud Pharmaceuticals Company Detail
11.6.2 Cloud Pharmaceuticals Business Overview
11.6.3 Cloud Pharmaceuticals Cloud-Based Drug Discovery Platforms Introduction
11.6.4 Cloud Pharmaceuticals Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.6.5 Cloud Pharmaceuticals Recent Development
11.7 WuXi AppTec
11.7.1 WuXi AppTec Company Detail
11.7.2 WuXi AppTec Business Overview
11.7.3 WuXi AppTec Cloud-Based Drug Discovery Platforms Introduction
11.7.4 WuXi AppTec Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.7.5 WuXi AppTec Recent Development
11.8 Dassault System
11.8.1 Dassault System Company Detail
11.8.2 Dassault System Business Overview
11.8.3 Dassault System Cloud-Based Drug Discovery Platforms Introduction
11.8.4 Dassault System Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.8.5 Dassault System Recent Development
11.9 Acelot
11.9.1 Acelot Company Detail
11.9.2 Acelot Business Overview
11.9.3 Acelot Cloud-Based Drug Discovery Platforms Introduction
11.9.4 Acelot Revenue in Cloud-Based Drug Discovery Platforms Business (2018-2023)
11.9.5 Acelot Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

IBM
Accenture
Tata Consultancy Services
SAS Institute
BioXcel
Cloud Pharmaceuticals
WuXi AppTec
Dassault System
Acelot

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂